Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Yersinia Diagnostics Market by Test types (Stool Culture, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy) and by Techniques (PCR, DNA Probes, Monoclonal Antibodies, Immunoassay, IT, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00417

Pages: NA

Charts: NA

Tables: NA

Yersinia is a rod-shaped, gram positive bacterium in the Enterobacteriaceae family that causes enterocolitis, terminal iletis, mesenteric lymphadenitis, acute diarrhea and sepsis. The pathogen species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis. These species of Yersinia cause the Bubonic plague and gastroenteritis respectively. The symptoms of the diseases caused by these bacteria include gastroenteritis, vomiting, abdominal pain, low grade fever and diarrhea. The infection usually occurs in children. This infection affects men more often than women. 

The treatment includes administration of cephalosporins, fluoroquinolones, tetracyclines, trimethoprim-sulfamethoxasole (TMP-SMZ) and aminoglycosides. There are several diagnostic tests that are performed to detect the infections, such as stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy etc. Several techniques such as PCR utilize monoclonal antibodies to identify the infections. As per the geographic analysis, North America holds the dominant share in the Yersinia diagnostics market due to the rising incidence of the infections. The Asia Pacific region is the fastest growing region due to the presence of untapped opportunities and high prevalence of infection in countries like India and Japan. 

Key benefits 

  • An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
  • Comprehensive analysis of the factors that drive and restrict the growth of the Yersinia diagnostics market is provided
  • Key regulatory guidelines of various regions which impact the Yersinia diagnostics market are critically examined 
  • Quantitative analysis of the current market and estimations are provided to showcase the financial caliber of the market
  • Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
  • Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the Yersinia diagnostics market     

 Key Market Segments

  • By Test types
    • Stool Culture
    • ELISA
    • Radioimmunoassay
    • Tube Agglutination
    • CT Scan
    • Ultrasonography
    • Colonoscopy
  • By Techniques
    • PCR
    • DNA Probes
    • Monoclonal Antibodies
    • Immunoassay
    • IT
    • Others
  • By Geography
    • North America
    • Asia Pacific
    • Europe
    • LAMEA

 
Key Market Players

  • Affymetrix Inc
  • Bio-Rad
  • Gen-probe
  • Abbott Laboratories

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: YERSINIA DIAGNOSTICS MARKET, BY TEST TYPES

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Test Types

    • 4.2. Stool Culture

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. ELISA

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Radioimmunoassay

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Tube Agglutination

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. CT Scan

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Ultrasonography

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Colonoscopy

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: YERSINIA DIAGNOSTICS MARKET, BY TECHNIQUES

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Techniques

    • 5.2. PCR

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. DNA Probes

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Monoclonal Antibodies

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Immunoassay

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. IT

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: YERSINIA DIAGNOSTICS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Test Types

      • 6.2.3. Market Size and Forecast, By Techniques

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Yersinia Diagnostics Market

        • 6.2.5.1. Market Size and Forecast, By Test Types
        • 6.2.5.2. Market Size and Forecast, By Techniques

      • 6.2.6. Canada Yersinia Diagnostics Market

        • 6.2.6.1. Market Size and Forecast, By Test Types
        • 6.2.6.2. Market Size and Forecast, By Techniques

      • 6.2.7. Mexico Yersinia Diagnostics Market

        • 6.2.7.1. Market Size and Forecast, By Test Types
        • 6.2.7.2. Market Size and Forecast, By Techniques

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Test Types

      • 6.3.3. Market Size and Forecast, By Techniques

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Yersinia Diagnostics Market

        • 6.3.5.1. Market Size and Forecast, By Test Types
        • 6.3.5.2. Market Size and Forecast, By Techniques

      • 6.3.6. Germany Yersinia Diagnostics Market

        • 6.3.6.1. Market Size and Forecast, By Test Types
        • 6.3.6.2. Market Size and Forecast, By Techniques

      • 6.3.7. Italy Yersinia Diagnostics Market

        • 6.3.7.1. Market Size and Forecast, By Test Types
        • 6.3.7.2. Market Size and Forecast, By Techniques

      • 6.3.8. Spain Yersinia Diagnostics Market

        • 6.3.8.1. Market Size and Forecast, By Test Types
        • 6.3.8.2. Market Size and Forecast, By Techniques

      • 6.3.9. UK Yersinia Diagnostics Market

        • 6.3.9.1. Market Size and Forecast, By Test Types
        • 6.3.9.2. Market Size and Forecast, By Techniques

      • 6.3.10. Russia Yersinia Diagnostics Market

        • 6.3.10.1. Market Size and Forecast, By Test Types
        • 6.3.10.2. Market Size and Forecast, By Techniques

      • 6.3.11. Rest Of Europe Yersinia Diagnostics Market

        • 6.3.11.1. Market Size and Forecast, By Test Types
        • 6.3.11.2. Market Size and Forecast, By Techniques

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Test Types

      • 6.4.3. Market Size and Forecast, By Techniques

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Yersinia Diagnostics Market

        • 6.4.5.1. Market Size and Forecast, By Test Types
        • 6.4.5.2. Market Size and Forecast, By Techniques

      • 6.4.6. Japan Yersinia Diagnostics Market

        • 6.4.6.1. Market Size and Forecast, By Test Types
        • 6.4.6.2. Market Size and Forecast, By Techniques

      • 6.4.7. India Yersinia Diagnostics Market

        • 6.4.7.1. Market Size and Forecast, By Test Types
        • 6.4.7.2. Market Size and Forecast, By Techniques

      • 6.4.8. South Korea Yersinia Diagnostics Market

        • 6.4.8.1. Market Size and Forecast, By Test Types
        • 6.4.8.2. Market Size and Forecast, By Techniques

      • 6.4.9. Australia Yersinia Diagnostics Market

        • 6.4.9.1. Market Size and Forecast, By Test Types
        • 6.4.9.2. Market Size and Forecast, By Techniques

      • 6.4.10. Thailand Yersinia Diagnostics Market

        • 6.4.10.1. Market Size and Forecast, By Test Types
        • 6.4.10.2. Market Size and Forecast, By Techniques

      • 6.4.11. Malaysia Yersinia Diagnostics Market

        • 6.4.11.1. Market Size and Forecast, By Test Types
        • 6.4.11.2. Market Size and Forecast, By Techniques

      • 6.4.12. Indonesia Yersinia Diagnostics Market

        • 6.4.12.1. Market Size and Forecast, By Test Types
        • 6.4.12.2. Market Size and Forecast, By Techniques

      • 6.4.13. Rest of Asia Pacific Yersinia Diagnostics Market

        • 6.4.13.1. Market Size and Forecast, By Test Types
        • 6.4.13.2. Market Size and Forecast, By Techniques

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Test Types

      • 6.5.3. Market Size and Forecast, By Techniques

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Yersinia Diagnostics Market

        • 6.5.5.1. Market Size and Forecast, By Test Types
        • 6.5.5.2. Market Size and Forecast, By Techniques

      • 6.5.6. South Africa Yersinia Diagnostics Market

        • 6.5.6.1. Market Size and Forecast, By Test Types
        • 6.5.6.2. Market Size and Forecast, By Techniques

      • 6.5.7. Saudi Arabia Yersinia Diagnostics Market

        • 6.5.7.1. Market Size and Forecast, By Test Types
        • 6.5.7.2. Market Size and Forecast, By Techniques

      • 6.5.8. UAE Yersinia Diagnostics Market

        • 6.5.8.1. Market Size and Forecast, By Test Types
        • 6.5.8.2. Market Size and Forecast, By Techniques

      • 6.5.9. Argentina Yersinia Diagnostics Market

        • 6.5.9.1. Market Size and Forecast, By Test Types
        • 6.5.9.2. Market Size and Forecast, By Techniques

      • 6.5.10. Rest of LAMEA Yersinia Diagnostics Market

        • 6.5.10.1. Market Size and Forecast, By Test Types
        • 6.5.10.2. Market Size and Forecast, By Techniques

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abbott Laboratories

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Gen-probe

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Bio-Rad

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Affymetrix Inc

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL YERSINIA DIAGNOSTICS MARKET, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR STOOL CULTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR ELISA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR RADIOIMMUNOASSAY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR TUBE AGGLUTINATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR CT SCAN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR ULTRASONOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR COLONOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL YERSINIA DIAGNOSTICS MARKET, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR PCR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR DNA PROBES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR IT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL YERSINIA DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL YERSINIA DIAGNOSTICS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA YERSINIA DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 20. U.S. YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 21. U.S. YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 22. CANADA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 23. CANADA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE YERSINIA DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 33. ITALY YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 34. ITALY YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 35. SPAIN YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 36. SPAIN YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 37. UK YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 38. UK YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 39. RUSSIA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 40. RUSSIA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 41. REST OF EUROPE YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 42. REST OF EUROPE YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC YERSINIA DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 44. ASIA-PACIFIC YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 45. ASIA-PACIFIC YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 46. CHINA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 47. CHINA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 48. JAPAN YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 49. JAPAN YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 50. INDIA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 51. INDIA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 52. SOUTH KOREA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 53. SOUTH KOREA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 54. AUSTRALIA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 55. AUSTRALIA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 56. THAILAND YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 57. THAILAND YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 58. MALAYSIA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 59. MALAYSIA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 60. INDONESIA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 61. INDONESIA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 62. REST OF ASIA PACIFIC YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 63. REST OF ASIA PACIFIC YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA YERSINIA DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 65. LAMEA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 66. LAMEA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 67. BRAZIL YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 68. BRAZIL YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH AFRICA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH AFRICA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 71. SAUDI ARABIA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 72. SAUDI ARABIA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 73. UAE YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 74. UAE YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 75. ARGENTINA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 76. ARGENTINA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 77. REST OF LAMEA YERSINIA DIAGNOSTICS, BY TEST TYPES, 2025-2033 ($MILLION)
  • TABLE 78. REST OF LAMEA YERSINIA DIAGNOSTICS, BY TECHNIQUES, 2025-2033 ($MILLION)
  • TABLE 79. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 80. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 81. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 82. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 83. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. GEN-PROBE: KEY EXECUTIVES
  • TABLE 85. GEN-PROBE: COMPANY SNAPSHOT
  • TABLE 86. GEN-PROBE: OPERATING SEGMENTS
  • TABLE 87. GEN-PROBE: PRODUCT PORTFOLIO
  • TABLE 88. GEN-PROBE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. BIO-RAD: KEY EXECUTIVES
  • TABLE 90. BIO-RAD: COMPANY SNAPSHOT
  • TABLE 91. BIO-RAD: OPERATING SEGMENTS
  • TABLE 92. BIO-RAD: PRODUCT PORTFOLIO
  • TABLE 93. BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. AFFYMETRIX INC: KEY EXECUTIVES
  • TABLE 95. AFFYMETRIX INC: COMPANY SNAPSHOT
  • TABLE 96. AFFYMETRIX INC: OPERATING SEGMENTS
  • TABLE 97. AFFYMETRIX INC: PRODUCT PORTFOLIO
  • TABLE 98. AFFYMETRIX INC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL YERSINIA DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL YERSINIA DIAGNOSTICS MARKET
  • FIGURE 3. SEGMENTATION YERSINIA DIAGNOSTICS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN YERSINIA DIAGNOSTICS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALYERSINIA DIAGNOSTICS MARKET
  • FIGURE 11. YERSINIA DIAGNOSTICS MARKET SEGMENTATION, BY BY TEST TYPES
  • FIGURE 12. YERSINIA DIAGNOSTICS MARKET FOR STOOL CULTURE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. YERSINIA DIAGNOSTICS MARKET FOR ELISA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. YERSINIA DIAGNOSTICS MARKET FOR RADIOIMMUNOASSAY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. YERSINIA DIAGNOSTICS MARKET FOR TUBE AGGLUTINATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. YERSINIA DIAGNOSTICS MARKET FOR CT SCAN, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. YERSINIA DIAGNOSTICS MARKET FOR ULTRASONOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. YERSINIA DIAGNOSTICS MARKET FOR COLONOSCOPY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. YERSINIA DIAGNOSTICS MARKET SEGMENTATION, BY BY TECHNIQUES
  • FIGURE 20. YERSINIA DIAGNOSTICS MARKET FOR PCR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. YERSINIA DIAGNOSTICS MARKET FOR DNA PROBES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. YERSINIA DIAGNOSTICS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. YERSINIA DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. YERSINIA DIAGNOSTICS MARKET FOR IT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. YERSINIA DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: YERSINIA DIAGNOSTICS MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. GEN-PROBE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. GEN-PROBE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. GEN-PROBE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. BIO-RAD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. BIO-RAD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. BIO-RAD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. AFFYMETRIX INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. AFFYMETRIX INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. AFFYMETRIX INC: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Yersinia Diagnostics Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved